Upcoming
Future-Proof Your Strategy. New Intelligence Subscriptions Arriving Soon! Schedule a demo! 
PDF
DataM
Interventional Cardiology and Peripheral Vascular Devices Market Report
SKU: MD4259

Interventional Cardiology and Peripheral Vascular Devices Market Size, Share & Forecast 2025-2033

Interventional Cardiology and Peripheral Vascular Devices Market is Segmented By Product type (Interventional Catheters, Guidewires, Stents, PTCA Balloons, Atherectomy Devices, Chronic Total Occlusion Devices, Synthetic Surgical Grafts, Embolic Protection Devices, IVC filters, Others), By Application(Congenital Heart Defect Correction, Coronary Thrombectomy, Angioplasty, Valvuloplasty, Percutaneous Valve Repair, Others), By End-user (Hospitals, Ambulatory Surgical Centers, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Last Updated: || Author: Mallikarjun Anne || Reviewed: Gopinadh Gundreddy

excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures

Global Interventional Cardiology and Peripheral Vascular Devices Market Size

The global interventional cardiology and peripheral vascular devices market reached US$ 20.11 billion in 2023, with a rise to US$ 21.58 billion in 2024, and is expected to reach US$ 41.17 billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.

Key Market Trends & Insights

  • North America accounted for approximately 40.2% of the global interventional cardiology and peripheral vascular devices market in 2023 and is expected to retain a significant market share throughout the forecast period.

  • Asia Pacific is anticipated to be the fastest-growing region, supported by expanding healthcare infrastructure, increasing prevalence of cardiovascular diseases, and growing demand for minimally invasive procedures.

  • By product type, the interventional catheters segment holds a dominant position due to its essential role in diagnostic and therapeutic cardiovascular interventions.

  • Continuous technological advancements in catheter design, imaging, and delivery systems are expected to further drive market growth and procedural success rates.

Market Size & Forecast

  • 2024 Market Size: USD 21.58 Billion

  • 2033 Projected Market Size: USD 41.17 Billion

  • CAGR (2025–2033): 7.5%

  • North America: Largest market in 2023

  • Asia Pacific: Fastest-growing market.

Executive Summary

Global Interventional Cardiology and Peripheral Vascular Devices Market

Market Dynamics: Drivers & Restraints

Driver: Rising Incidence of Cardiovascular Diseases (CVDs)

The escalating global prevalence of cardiovascular diseases (CVDs) is a primary catalyst propelling the growth of the interventional cardiology and peripheral vascular devices market. CVDs, encompassing conditions such as coronary artery disease, heart failure, and peripheral artery disease, are now the leading cause of death worldwide. In 2022, CVDs were responsible for approximately 19.8 million deaths globally, reflecting a substantial increase from 12.4 million in 1990. This surge is attributed to factors like aging populations, urbanization, and lifestyle changes, including poor diet, physical inactivity, and tobacco use.

The increasing burden of CVDs necessitates timely and effective medical interventions. Minimally invasive procedures, facilitated by advanced interventional devices, offer significant advantages in treating these conditions. For instance, coronary stenting, angioplasty, and atherectomy procedures are essential for managing coronary artery disease, while peripheral vascular interventions address blockages in peripheral arteries. The demand for these procedures is expected to rise in tandem with the growing incidence of CVDs, thereby driving the market for related devices.

Furthermore, the projected increase in global CVD cases underscores the need for continued innovation and investment in interventional cardiology and peripheral vascular devices. As the prevalence of CVDs continues to rise, the market for these devices is anticipated to expand, offering opportunities for healthcare providers and manufacturers to meet the evolving needs of patients worldwide.

Restraint: High Device and Procedure Costs

The high costs associated with interventional cardiology and peripheral vascular devices, along with the procedures themselves, pose a significant challenge to market growth. Advanced technologies such as drug-eluting stents, specialized catheters, and imaging systems often come with substantial price tags, making them less accessible in cost-sensitive healthcare settings and emerging markets. As a result, high device and procedure costs continue to act as a barrier, particularly in lower-income regions, slowing the overall expansion of the interventional cardiology and peripheral vascular devices market.

For more details on this report, Request for Sample

Segmentation Analysis

The global interventional cardiology and peripheral vascular devices market is segmented based on product type, application, end-user, and region.

Treatment Type - The interventional catheters segment is estimated to have 32.8% of the interventional cardiology and peripheral vascular devices market share.

The interventional catheters segment is poised to dominate the interventional cardiology and peripheral vascular devices market due to its essential role in nearly all minimally invasive cardiovascular procedures. These catheters are critical for accessing, navigating, and treating vascular conditions. The growing adoption of advanced diagnostic and therapeutic techniques, such as intravascular ultrasound (IVUS) and fractional flow reserve (FFR) measurements, is driving demand for specialized catheters that enhance procedural precision and patient outcomes. 

Additionally, continuous technological advancements improving catheter flexibility, durability, and imaging capabilities are expanding their use across a wider range of cardiovascular interventions. As cardiovascular disease prevalence rises globally and the shift toward minimally invasive treatments accelerates, interventional catheters remain indispensable tools, securing their leading position in the market.

interventional catheters segment

Geographical Analysis

The North America Interventional cardiology and peripheral vascular devices market was valued at 39.7% market share in 2024

North America holds a leading position in the interventional cardiology and peripheral vascular devices market, driven by a combination of clinical demand, technological leadership, and strong healthcare infrastructure. The region, particularly the United States, faces a high and rising prevalence of cardiovascular and peripheral artery diseases, which fuels consistent demand for minimally invasive interventions. This is supported by advanced healthcare systems equipped with modern catheter labs and surgical centers capable of adopting and integrating the latest devices. 

Major global players such as Medtronic, Abbott, and Boston Scientific are headquartered in the U.S., allowing North America to remain at the forefront of innovation with rapid development and commercialization of next-generation devices like drug-eluting stents, atherectomy systems, and bioresorbable scaffolds. For instance, in August 2025, Boston Scientific announced the initiation of a new clinical trial aimed at evaluating its Agent Drug-Coated Balloon (DCB) against the current standard of care. 

Additionally, strategic mergers and acquisitions in the region have expanded product portfolios and consolidated market strength. Altogether, these factors ensure North America remains the most dominant and mature market for interventional cardiology and peripheral vascular devices.

Major Players

The major players in the interventional cardiology and peripheral vascular devices market include B. Braun Interventional Systems Inc., Boston Scientific Corporation, BD, Medtronic, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co., Ltd, TERUMO CORPORATION, Cook, Shenzhen MicroApproach Medical Technology Co., Ltd, and Biotronik, among others.

Key Developments:

  • In May 2024, Abbott announced the launch of the XIENCE Sierra  Everolimus-Eluting Coronary Stent System in India. As one of the newest additions to the trusted XIENCE stent family, XIENCE Sierra is now accessible to patients with blocked coronary arteries, offering advanced treatment options. Designed for complex coronary interventions, the system delivers exceptional safety and performance, empowering interventional cardiologists to navigate and treat even the most challenging cases with greater confidence.

Report Scope

Metrics

Details

CAGR

7.5%

Market Size Available for Years

2022-2033

Estimation Forecast Period

2025-2033

Revenue Units

Value (US$ Bn) 

Segments Covered

Product Type

Interventional Catheters, Guidewires, Stents, Atherectomy Devices, PTCA Balloons, Chronic Total Occlusion Devices, Synthetic Surgical Grafts, Embolic Protection Devices, Others

Application

Angioplasty, Coronary Thrombectomy, Congenital Heart Defect Correction, Valvuloplasty, Percutaneous Valve Repair, Others

 

End-User

Hospitals, Ambulatory Surgical Centers, Others

Regions Covered

North America, Europe, Asia-Pacific, South America, and the Middle East & Africa

 

The global interventional cardiology and peripheral vascular devices market report delivers a detailed analysis with 73 key tables, more than 76 visually impactful figures, and 195 pages of expert insights, providing a complete view of the market landscape.

Suggestions for Related Report

For more medical device-related reports, please click here

FAQ’s

  • Interventional Cardiology and Peripheral Vascular Devices Market is expected to grow at a CAGR of 7.50% during the forecast period 2024-2031

  • North America region holds the largest market share in the global interventional cardiology and peripheral vascular devices market.

  • leading end users for the interventional cardiology and peripheral vascular devices market Hospitals, Ambulatory Surgical Centers

  • Spectranetics, Hexacath, Lepu Medical Technology, Shenzhen MicroApproach Medical Technology and Medtronic Inc.

  • The market is expected to grow steadily due to an aging population, rising cardiovascular disease burden, and technological innovation in next-generation vascular devices.
Related Reports
medical-devices iconmedical-devices
Europe Electronic Stethoscope Market Size, Share, Industry, Forecast and outlook (2024-2031)
medical-devices iconmedical-devices
Pediatric Interventional Cardiology Market Size, Share, Industry, Forecast and outlook (2024-2031)
medical-devices iconmedical-devices
Heart Failure POC and LOC Devices Market Size, Share Analysis, Growth Trends and Forecast 2025-2033
medical-devices iconmedical-devices
Transcatheter Tricuspid Valve Intervention (TTVI) Market Size, Share, Industry, Forecast and outlook (2024-2031)
medical-devices iconmedical-devices
Cardiovascular Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)
medical-devices iconmedical-devices
Automated External Defibrillator Market Size, Share, Industry, Forecast and outlook (2024-2031)